Europe Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market, By Product (Electrosurgery Instruments, Endoscope, Visualization and Robotic Surgical System, Hand Instruments, Access Instruments, Surgical Suture and Stapler Devices, Energy/Vessel Sealing Devices, Fluid Management Systems, Stents, and Others), Indication (Liver Cancer, Pancreatic Cancer, Bile Duct Cancer, Gall Stones, Pancreatitis, Cirrhosis, Cholesystitis, and Others), Type of Surgery (Open Surgery and Minimally-Invasive Surgery), Age Group (Pediatric, Adults, and Geriatric), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Trauma Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) - Industry Trends and Forecast to 2030.
Europe Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market Analysis and Size
The demand for HPB surgeries rises due to increasing cases of liver and pancreatic diseases worldwide. The market for surgical devices in this domain is expected to expand, driven by technological advancements and the need for improved patient care. The Europe Hepato-Pancreatico-Biliary (HPB) surgeries surgical devices market is expected to drive market growth in the forecast period of 2023 to 2030.
Data Bridge Market Research analyses that the market is growing with a CAGR of 7.9% in the forecast period of 2023 to 2030 and is expected to reach USD 2,359,422.54 thousand by 2030. The growing prevalence of diseases associated with the liver, pancreas, and bile ducts act as a driver for market growth.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Year
|
2021 (Customizable 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Thousand
|
|
Segments Covered
|
Product (Electrosurgery Instruments, Endoscope, Visualization and Robotic Surgical System, Hand Instruments, Access Instruments, Surgical Suture and Stapler Devices, Energy/Vessel Sealing Devices, Fluid Management Systems, Stents, and Others), Indication (Liver Cancer, Pancreatic Cancer, Bile Duct Cancer, Gall Stones, Pancreatitis, Cirrhosis, Cholesystitis, and Others), Type of Surgery (Open Surgery and Minimally-Invasive Surgery), Age Group (Pediatric, Adults, and Geriatric), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Trauma Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others)
|
|
Countries Covered
|
Germany, France, U.K., Hungary, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Russia, Turkey, Netherlands, Switzerland, and Rest of Europe
|
|
Market Players Covered
|
Medtronic, Cook, Olympus Corporation, B. Braun SE, Boston Scientific Corporation, CONMED Corporation, BD, CooperSurgical Inc, KARL STORZ, Terumo Europe NV, Medorah Meditek Pvt. Ltd, STERIS, Medi-Globe GmbH, Mediflex Surgical Products, Thompson Surgical, FUJIFILM Corporation, and Johnson & Johnson Services, Inc. among others
|
Europe Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market Definition
HPB surgeries involve complex procedures on the liver, pancreas, and biliary system, addressing conditions ranging from tumors and cysts to chronic diseases. Surgical devices play a pivotal role in these procedures, facilitating the precise and safe manipulation of delicate tissues and organs. These devices include specialized laparoscopic tools, cutting-edge robotic systems, and advanced imaging equipment such as intraoperative ultrasound. HPB surgeries require high precision, and surgical devices are meticulously designed to ensure minimal tissue damage and improved patient outcomes. Innovations in this field continue to evolve, focusing on enhancing surgical precision, reducing recovery times, and optimizing post-operative care.
Europe Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail as below:
Drivers
- Increasing Number of Diseases Associated with Liver and Pancreas
The escalating prevalence of diseases linked to the liver and pancreas has emerged as a pivotal factor propelling the market growth. In recent years, the healthcare landscape has witnessed a notable surge in conditions such as liver cirrhosis, hepatocellular carcinoma, pancreatic cancer, and chronic pancreatitis among others. This surge in diseases affecting the liver and pancreas has created a substantial demand for advanced surgical interventions and innovative medical devices. The healthcare industry is witnessing a surge in the number of HPB surgeries performed as these hepato-pancreatic conditions become more prevalent globally. These surgical procedures necessitate a range of specialized devices and instruments designed to facilitate complex surgeries, minimize risks, and improve patient outcomes.
Consequently, the increasing demand for HPB surgeries and the corresponding need for surgical devices have propelled market growth. This trend is likely to persist as healthcare professionals and medical device manufacturers continue to innovate and improve surgical techniques and devices for better patient care. Thus, the rising incidence of liver and pancreas-related diseases is driving market growth.
- Growing Trend of Gallbladder Concerns in Younger Adults
The emerging trend of gallbladder concerns among younger adults is expected to significantly impact market growth. Typically, gallbladder issues have been more commonly associated with older individuals. However, there has been a notable shift in recent years, with an increasing number of younger adults experiencing gallbladder-related problems. This shift can be attributed to evolving lifestyles, dietary habits, and environmental factors that contribute to the development of gallstones and other gallbladder disorders in a younger demographic. Simultaneously, there is more chance of having a malignant or benign disease in the associated organs. Consequently, healthcare providers are witnessing a rising demand for HPB surgeries in younger patients, specifically those related to the gallbladder.
Hence, the escalating trend of gallbladder cancer is poised to boost the demand for HPB surgeries significantly. Gallbladder cancer, often detected at an advanced stage, necessitates intricate surgical interventions as a key treatment modality. There is a growing need for specialized surgical procedures and cutting-edge HPB surgical devices to effectively address the condition as the incidence of this aggressive cancer continues to rise, which driving the market growth.
Opportunities
- Incorporation of AI Technology in Surgical Devices
Incorporating AI (Artificial Intelligence) technology into surgical devices presents a remarkable opportunity for market growth. AI has the potential to revolutionize the field of HPB surgery by enhancing precision, improving patient outcomes, and reducing the overall complexity of these intricate procedures. AI can assist surgeons in several ways, such as image analysis for better preoperative planning and intraoperative guidance. Machine learning algorithms can process vast amounts of medical data, enabling more accurate diagnoses and surgical strategies tailored to each patient's unique anatomy. During surgery, AI-powered surgical devices can provide real-time feedback and assistance to surgeons, helping them make more informed decisions and execute precise movements.
Integrating AI into surgical devices holds immense promise for the HPB surgeries and surgical devices market as AI technology continues to advance, attracting healthcare providers and surgeons looking to improve the quality of care they provide, which is expected to create opportunities for market growth.
Restraint/Challenge
- Lack of Proper Healthcare Facilities in Developing Regions
The lack of adequate healthcare facilities in developing regions is anticipated to pose a significant challenge for market growth. In many developing countries, healthcare infrastructure and resources are limited, often resulting in delayed diagnoses and limited access to advanced surgical treatments. Patients in these regions may not have timely access to specialized HPB surgeons and state-of-the-art surgical devices, leading to postponed or suboptimal care. This disparity in healthcare facilities and expertise can hinder the demand for HPB surgeries and related devices.
Furthermore, the high cost associated with HPB surgeries and surgical devices can be a barrier for patients in developing regions who may struggle to afford such treatments. Healthcare systems in these areas may also lack the necessary funding and resources to invest in advanced surgical technologies, which is expected to challenge market growth.
Recent Developments
- In August 2023, Boston Scientific Corporation declared the POLARxTM Cryoablation System has been given the U.S. Food and Drug Administration (FDA) approval. The new system uses the POLARx FIT Cryoablation Balloon Catheter, a device with the unusual ability to enable two balloon sizes—28 and 31mm—in one catheter. This catheter is indicated for the treatment of patients with paroxysmal Atrial Fibrillation (AF). This approval of newly launched products will help the companygain more brand value and customer reliability.
- In September 2022, CONMED Corporation announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will take part in a fireside chat at the 20th Annual Morgan Stanley Europe Healthcare Conference, which will take place on September 13, 2022. This participation has helped the company gain more recognition among competitors and customers.
- In April 2022, FUJIFILM Corporation announced the availability of Sonosite LX, the industry leader’s latest premium point-of-care ultrasound system in Canada. This helped the company to expand its product portfolio.
- In August 2021, Cook Medical announced that it was expanding its Illinois facility and is hiring over 100 manufacturing employees and five professional positions at its facility in Canton, Illinois. The expanded manufacturing capabilities will help Cook meet patient and customer demand for its medical devices.
- In July 2021, BD announced it had acquired Tepha, Inc., a leading developer and manufacturer of a proprietary resorbable polymer technology. This strategic acquisition advances BD's category leadership in surgical mesh and enables future innovations to provide new solutions to physicians and their patients.
Europe Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market Scope
The Europe Hepato-Pancreatico-Biliary (HPB) surgeries surgical devices market is categorized into six notable segment based on product, indication, age group, type of surgery end users, and distribution channel. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Electrosurgery Instruments
- Endoscope
- Hand Instruments
- Access Instruments
- Stents
- Energy/Vessel Sealing Devices
- Visualization and Robotic Surgical System
- Surgical Suture and Stapler Devices
- Fluid Management System
- Others
On the basis of product, the market is segmented into electrosurgery instruments, endoscope, visualization and robotic surgical system, hand instruments, access instruments, surgical suture and stapler devices, energy/vessel sealing devices, fluid management systems, stents, and others.
Indication
- Liver Cancer
- Pancreatic Cancer
- Gall Stones
- Bile Duct Cancer
- Cirrhosis
- Pancreatitis
- Cholecystitis
- Others
On the basis of indication, the market is segmented into liver cancer, pancreatic cancer, gall stones, bile duct cancer, cirrhosis, pancreatitis, cholesystitis, and others.
Type of Surgery
- Open Surgery
- Minimally-Invasive Surgery
On the basis of type of surgery, the market is segmented into open surgery and minimally-invasive surgery.
Age Group
- Adults
- Geriatrics
- Pediatric
On the basis of age group, the market is segmented into adults, geriatrics, and pediatric.
End User
- Hospitals
- Specialty Clinics
- Trauma Centers
- Ambulatory Surgical Centers
- Others
On the basis of end user, the market is segmented into hospitals, specialty clinics, trauma centers, ambulatory surgical centers, and others.
Distribution Channel
- Direct Tenders
- Retail Sales
- Others
On the basis of distribution channel, the market is segmented into direct tenders, retail sales, and others.
Regional Analysis/Insights: Europe Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
The Europe Hepato-Pancreatico-Biliary (HPB) surgeries surgical devices market is analyzed, and market size insights and trends are provided by product, indication, type of surgery, age group, end users, and distribution channel as referenced above.
The countries covered in the Europe Hepato-Pancreatico-Biliary (HPB) surgeries surgical devices market report are Germany, France, U.K., Hungary, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Russia, Turkey, Netherlands, Switzerland, and Rest of Europe.
Germany is expected to dominate the market due to its advanced healthcare infrastructure and extensive network of high-quality clinical centres.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Share Analysis: Europe Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market
The Europe Hepato-Pancreatico-Biliary (HPB) surgeries surgical devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus on the market.
Some of the major players operating in the market are Medtronic, Cook, Olympus Corporation, B. Braun SE, HOBBS MEDICAL INC., TeleMed Systems, Inc., Comepa, Boston Scientific Corporation, CONMED Corporation, BD, CooperSurgical Inc, KARL STORZ, Terumo Europe NV, Medorah Meditek Pvt. Ltd, STERIS, Medi-Globe GmbH, Mediflex Surgical Products, Thompson Surgical, FUJIFILM Corporation, and Johnson & Johnson Services, Inc., among others.
SKU-